Article
Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
Skeletal muscle - 1 Jan 2016
Roy Pauline, Rau Fredérique, Ochala Julien, Messéant Julien, Fraysse Bodvael, Lainé Jeanne, Agbulut Onnik, Butler-Browne Gillian, Furling Denis, Ferry Arnaud
Abstract excerpt
BACKGROUND: The greater susceptibility to contraction-induced skeletal muscle injury (fragility) is an important dystrophic feature and tool for testing preclinic dystrophin-based therapies for Duchenne muscular dystrophy. However, how these therapies reduce the muscle fragility is not clear. METHODS: To address this question, we first determined the event(s) of the excitation-contraction cycle which is/are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
